Crédit Agricole CIB Financial Solutions Stock

Crédit Agricole CIB Financial Solutions Share Price

XS2638710819

Market Closed - Börse Stuttgart 11:11:22 28/06/2024 BST
98.71 ^USD	-0.44%

Current month	+1.83%
1 month	+0.67%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes

Chart BRISTOL-MYERS SQUIBB COMPANY

Chart Crédit Agricole CIB Financial Solutions

Latest news about BRISTOL-MYERS SQUIBB COMPANY

Purple Biotech Says Interim Data from Pancreatic Cancer Drug Study Shows Promise	06-27	MT
2seventy bio Sells Hemophilia A Candidate, Gene Editing Technology to Novo Nordisk; Shares Rise After Hours	06-26	MT
Top Midday Stories: Southwest Cuts Q2 Guidance; HHS to Lower Costs for Medicare Enrollees on 64 Drugs; Bosch Weighing Acquisition Offer for Whirlpool; Novo Nordisk to Record $816.2 Million Impairment	06-26	MT
Biden Administration to Lower Costs for 64 Prescription Drugs for Medicare Enrollees	06-26	MT

More news

Quotes 5-day view

Date	Price	Change
28/06/24	98.71	-0.44%
27/06/24	99.15	+0.20%
26/06/24	98.95	-0.05%
25/06/24	99	+0.51%
24/06/24	98.5	+0.60%

Delayed Quote Börse Stuttgart

Last update June 28, 2024 at 11:11 am

More quotes

Static data

Product type	sonstige Zertifikate
Buy / Sell	CALL
Underlying	BRISTOL-MYERS SQUIBB COMPANY
Issuer	Crédit Agricole
WKN	A4AEGA
ISIN	XS2638710819
Date issued	24/01/2024
Strike	49.98 $
Maturity	17/01/2025 (202 Days)
Parity	0.05 : 1
Emission price	100 $
Emission volume	N/A
Settlement	Beides
Currency	USD

Technical Indicators

Highest since issue	101.7 $
Lowest since issue	96.94 $
Spread	5 $
Spread %	0.50%

Company Profile

Bristol-Myers Squibb Company est spécialisé dans le développement, la fabrication et la commercialisation de produits pharmaceutiques. Les produits sont destinés au traitement des cancers, des maladies cardio-vasculaires, de l'hépatite, des maladies immunitaires et des désordres psychiatriques. The United States account for 70.1% of net sales.

Sector

More about the company

Ratings for Bristol-Myers Squibb Company

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Consensus: Bristol-Myers Squibb Company

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

41.53 USD

Average target price

53.19 USD

Spread / Average Target

+28.09%

Consensus